Mergers & Acquisitions ·
AtaiBeckley Inc. held a virtual special meeting of stockholders on September 8, 2026, to vote on the adoption of its…
ATAIAtaiBeckley Inc.
AtaiBeckley Inc. held a virtual special meeting of stockholders on September 8, 2026, to vote on the adoption of its Merger Agreement with Eli Lilly and Company. The merger proposal was approved by approximately 97.6% of votes cast, with 237,762,253 shares voting in favor against 5,033,755 opposed, representing about 65.6% of outstanding shares present or represented. Assuming satisfaction of closing conditions, the merger is expected to be consummated on September 11, 2026. AtaiBeckley Inc. operates in the biotechnology industry, focusing on the development of treatments for mental health disorders.